High-Throughput Analysis of Global DNA Methylation Using Methyl-Sensitive Digestion.

Area of Science:

• Epigenetics and Molecular Biology
• Cancer Research
• Pharmacology

Background:

• Aberrant DNA methylation is a hallmark of various diseases, particularly cancer.
• Existing methods for assessing global DNA methylation are limited for large-scale drug screening.
• Epigenetic drugs and diagnostic markers for DNA methylation are gaining clinical interest.

Purpose of the Study:

• To improve a fluorescence polarization-based assay for reliable global DNA methylation measurement in human genomic DNA.
• To establish a high-throughput screening system for compounds affecting DNA methylation states.
• To validate the assay's utility in cancer diagnosis.

Main Methods:

• Development and optimization of a methyl-sensitive fluorescence polarization (MSFP) assay.
• Utilized a 384-well plate format for high-throughput processing.
• Compared MSFP results with LINE-1 pyrosequencing for validation.

Main Results:

• The MSFP assay demonstrated high repeatability (CV = 1.5%) and accuracy (r2 = 0.99).
• Requires minimal DNA input (50-80 ng) and completes in under 3.5 hours.
• Showed significant correlation with the established LINE-1 pyrosequencing assay.

Conclusions:

• MSFP is a simple, rapid, and accurate method for assessing global DNA methylation.
• The assay is suitable for pre-screening epigenetic drug candidates.
• MSFP holds potential for the diagnosis of specific cancer types.